236 related articles for article (PubMed ID: 8870112)
1. Distinctive features of idiopathic inflammatory myopathies in French Canadians.
Uthman I; Vázquez-Abad D; Senécal JL
Semin Arthritis Rheum; 1996 Aug; 26(1):447-58. PubMed ID: 8870112
[TBL] [Abstract][Full Text] [Related]
2. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.
Troyanov Y; Targoff IN; Tremblay JL; Goulet JR; Raymond Y; Senécal JL
Medicine (Baltimore); 2005 Jul; 84(4):231-249. PubMed ID: 16010208
[TBL] [Abstract][Full Text] [Related]
3. Retrospective review of the clinical manifestations and outcomes in Puerto Ricans with idiopathic inflammatory myopathies.
Ríos G
J Clin Rheumatol; 2005 Jun; 11(3):153-6. PubMed ID: 16357735
[TBL] [Abstract][Full Text] [Related]
4. Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population.
Manwatkar A; Padiyar S; Nair A; Jha A; Kumar S; Yadav B; Prakash JAJ; Das JK; Mathew J
Clin Rheumatol; 2023 Dec; 42(12):3289-3297. PubMed ID: 37801141
[TBL] [Abstract][Full Text] [Related]
5. [Dermatomyositis and polymyositis: clinical aspects and treatment].
Hachulla E
Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087
[TBL] [Abstract][Full Text] [Related]
6. Anti-Ku antibody-positive systemic sclerosis and idiopathic inflammatory myopathies overlap syndrome in children: a report of two cases and a review of the literature.
Kanda S; Shimbo A; Nakamura Y; Matsuno R; Kaneko S; Irabu H; Kaneko K; Shimizu M
Clin Rheumatol; 2023 Dec; 42(12):3411-3417. PubMed ID: 37393558
[TBL] [Abstract][Full Text] [Related]
7. Proinflammatory Histidyl-Transfer RNA Synthetase-Specific CD4+ T Cells in the Blood and Lungs of Patients With Idiopathic Inflammatory Myopathies.
Galindo-Feria AS; Albrecht I; Fernandes-Cerqueira C; Notarnicola A; James EA; Herrath J; Dastmalchi M; Sandalova T; Rönnblom L; Jakobsson PJ; Fathi M; Achour A; Grunewald J; Malmström V; Lundberg IE
Arthritis Rheumatol; 2020 Jan; 72(1):179-191. PubMed ID: 31403245
[TBL] [Abstract][Full Text] [Related]
8. Juvenile Dermatomyositis: Advances in Pathogenesis, Assessment, and Management.
Leung AKC; Lam JM; Alobaida S; Leong KF; Wong AHC
Curr Pediatr Rev; 2021; 17(4):273-287. PubMed ID: 33902423
[TBL] [Abstract][Full Text] [Related]
9. Successful combination therapy of cyclosporine and methotrexate for refractory polymyositis with anti-Jo-1 antibody: a case report.
Chang HK; Lee DH
J Korean Med Sci; 2003 Feb; 18(1):131-4. PubMed ID: 12589104
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of B-cell activating factor of the TNF family (BAFF) correlate with anti-Jo-1 autoantibodies levels and disease activity in patients with anti-Jo-1positive polymyositis and dermatomyositis.
Kryštůfková O; Hulejová H; Mann HF; Pecha O; Půtová I; Ekholm L; Lundberg IE; Vencovský J
Arthritis Res Ther; 2018 Jul; 20(1):158. PubMed ID: 30053824
[TBL] [Abstract][Full Text] [Related]
11. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
[TBL] [Abstract][Full Text] [Related]
12. Dermatomyositis and polymyositis: new treatment targets on the horizon.
Hak AE; de Paepe B; de Bleecker JL; Tak PP; de Visser M
Neth J Med; 2011 Oct; 69(10):410-21. PubMed ID: 22058260
[TBL] [Abstract][Full Text] [Related]
13. [Anti-Jo-1 antibodies: specific autoantibodies for polymyositis with interstitial pulmonary fibrosis. 2 case reports].
Fischer E; Thiele A; Stierle HE; Lang B
Z Rheumatol; 1995; 54(3):171-7. PubMed ID: 7660688
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.
Pozharashka J; Dourmishev L; Rusinova D; Balabanova M; Miteva L
Acta Dermatovenerol Croat; 2020 Aug; 28(2):120-122. PubMed ID: 32876041
[TBL] [Abstract][Full Text] [Related]
15. High frequencies and co-existing of myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies overlapped to rheumatoid arthritis.
Nakajima A; Yoshino K; Soejima M; Kawaguchi Y; Satoh T; Kuwana M; Yamanaka H
Rheumatol Int; 2012 Jul; 32(7):2057-61. PubMed ID: 21479881
[TBL] [Abstract][Full Text] [Related]
16. Anti-Jo-1 antibodies.
Zampieri S; Ghirardello A; Iaccarino L; Tarricone E; Gambari PF; Doria A
Autoimmunity; 2005 Feb; 38(1):73-8. PubMed ID: 15804708
[TBL] [Abstract][Full Text] [Related]
17. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy.
Ichimura Y; Matsushita T; Hamaguchi Y; Kaji K; Hasegawa M; Tanino Y; Inokoshi Y; Kawai K; Kanekura T; Habuchi M; Igarashi A; Sogame R; Hashimoto T; Koga T; Nishino A; Ishiguro N; Sugimoto N; Aoki R; Ando N; Abe T; Kanda T; Kuwana M; Takehara K; Fujimoto M
Ann Rheum Dis; 2012 May; 71(5):710-3. PubMed ID: 22258483
[TBL] [Abstract][Full Text] [Related]
18. Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: Relevance for clinical classification: retrospective study of 169 patients.
Váncsa A; Gergely L; Ponyi A; Lakos G; Németh J; Szodoray P; Dankó K
Joint Bone Spine; 2010 Mar; 77(2):125-30. PubMed ID: 20188618
[TBL] [Abstract][Full Text] [Related]
19. An effective algorithm for the serological diagnosis of idiopathic inflammatory myopathies: The key role of anti-Ro52 antibodies.
Infantino M; Manfredi M; Grossi V; Benucci M; Morozzi G; Tonutti E; Tampoia M; Bizzaro N
Clin Chim Acta; 2017 Dec; 475():15-19. PubMed ID: 28986052
[TBL] [Abstract][Full Text] [Related]
20. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.
Kao AH; Lacomis D; Lucas M; Fertig N; Oddis CV
Arthritis Rheum; 2004 Jan; 50(1):209-15. PubMed ID: 14730618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
